Health

Pfizer, BioNTech request COVID-19 vaccine emergency authorization for kids ages 5 to 11



Pfizer and BioNTech requested Food and Drug Administration emergency authorization of their COVID-19 vaccine for children ages 5 to 11, the companies announced Thursday.Pfizer took to Twitter to share the news, writing: “With new cases in children in the U.S. continuing to be at a high level, this submission is an important step in our ongoing effort against #COVID19.”CLICK HERE FOR FULL CORONAVIRUS COVERAGEThe news comes just over a week after Pfizer-BioNTech submitted clinical trial data from a COVID-19 vaccine study among kids ages 5-11 to the FDA. Trial data included recent findings among 2,268 participants ages 5-11, which suggested a smaller dose shot was safe, well tolerated and resulted in neutralizing antibody responses.The companies previously announced that trial results on younger age groups, like children ages 6 months to under 5 years, are expected by the fourth quarter.This is a developing story, please check back for updates.



Source link

You Missed

Centre's refusal to allow Sikh pilgrimage to Pakistan sparks outrage in Punjab
Top StoriesSep 15, 2025

केंद्र सरकार की पाकिस्तान में सिख तीर्थयात्रा की अनुमति न देने से पंजाब में गुस्सा फूटा

चंडीगढ़: सुरक्षा संबंधी चिंताओं को देखते हुए केंद्र सरकार ने पाकिस्तान के लिए गुरु नानक देव जी के…

Political row erupts in Gujarat as BJP refuses to bear former CM Rupani's funeral expenses
Top StoriesSep 15, 2025

गुजरात में भाजपा के पूर्व सीएम रुपानी के अंतिम संस्कार के खर्चों को वहन करने से इनकार करने के बाद राजनीतिक विवाद फूट पड़ा है

रुपानी के अंतिम संस्कार के दौरान भाजपा के शानदार समारोह के पीछे एक चौंकाने वाला मोड़ उभर रहा…

Scroll to Top